---
title: "百川發佈最強循證增強大模型 M2 Plus，超越美國最火醫療應用 OpenEvidence"
description: "百川智能今日發佈循證增強醫療大模型 Baichuan-M2 Plus，同步升級配套應用百小應並開放 API。 評測顯示，M2 Plus 的醫療幻覺率較通用大模型顯著降低，相比 DeepSeek 低約 3 倍，優於美國最火醫療產品 OpenEvidence，可信度比肩資深臨牀醫生水準。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/262167957.md"
published_at: "2025-10-22T06:10:51.000Z"
---

# 百川發佈最強循證增強大模型 M2 Plus，超越美國最火醫療應用 OpenEvidence

> 百川智能今日發佈循證增強醫療大模型 Baichuan-M2 Plus，同步升級配套應用百小應並開放 API。 評測顯示，M2 Plus 的醫療幻覺率較通用大模型顯著降低，相比 DeepSeek 低約 3 倍，優於美國最火醫療產品 OpenEvidence，可信度比肩資深臨牀醫生水準。

百川智能今日發佈循證增強醫療大模型 Baichuan-M2 Plus，同步升級配套應用百小應並開放 API。 評測顯示，M2 Plus 的醫療幻覺率較通用大模型顯著降低，相比 DeepSeek 低約 3 倍，優於美國最火醫療產品 OpenEvidence，可信度比肩資深臨牀醫生水準。

### Related Stocks

- [DPSK.NA - 深度求索](https://longbridge.com/zh-HK/quote/DPSK.NA.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| OpenAI Warns Congress on DeepSeek Distillation Tactics | OpenAI has alerted US lawmakers about its Chinese competitor DeepSeek, which may be employing advanced distillation tact | [Link](https://longbridge.com/zh-HK/news/275935776.md) |
| AgelessRx Expands Access to Multi-Cancer Early Detection Solutions, in Honor of Cancer Prevention Month | AgelessRx is expanding access to its multi-cancer early detection solutions in honor of Cancer Prevention Month. This in | [Link](https://longbridge.com/zh-HK/news/276180967.md) |
| Minimax releases 'Minimax-M2.5' - website | Minimax releases 'Minimax-M2.5' - website | [Link](https://longbridge.com/zh-HK/news/275615681.md) |
| Xsolis Announces the Appointment of Vic Pierni as Chief Financial Officer | Xsolis has appointed Vic Pierni as Chief Financial Officer. Pierni, a CPA with over 25 years of experience in financial  | [Link](https://longbridge.com/zh-HK/news/276187646.md) |
| ZAWYA-PRESSR: Frimex acquires 60% stake in Gulf Neo Care to establish a strategic healthcare platform in Saudi Arabia | Frimex International Investment Company has acquired a 60% stake in Gulf Neo Care, a Saudi firm specializing in neonatal | [Link](https://longbridge.com/zh-HK/news/276105068.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。